169 related articles for article (PubMed ID: 27181208)
1. eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis.
Cheng Y; Ren X; Yuan Y; Shan Y; Li L; Chen X; Zhang L; Takahashi Y; Yang JW; Han B; Liao J; Li Y; Harvey H; Ryazanov A; Robertson GP; Wan G; Liu D; Chen AF; Tao Y; Yang JM
Oncogene; 2016 Dec; 35(49):6293-6308. PubMed ID: 27181208
[TBL] [Abstract][Full Text] [Related]
2. Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer.
Bircan HA; Gurbuz N; Pataer A; Caner A; Kahraman N; Bayraktar E; Bayraktar R; Erdogan MA; Kabil N; Ozpolat B
Lung Cancer; 2018 Oct; 124():31-39. PubMed ID: 30268477
[TBL] [Abstract][Full Text] [Related]
3. Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.
Tekedereli I; Alpay SN; Tavares CD; Cobanoglu ZE; Kaoud TS; Sahin I; Sood AK; Lopez-Berestein G; Dalby KN; Ozpolat B
PLoS One; 2012; 7(7):e41171. PubMed ID: 22911754
[TBL] [Abstract][Full Text] [Related]
4. What is the impact of eukaryotic elongation factor 2 kinase on cancer: A systematic review.
Li S; Li Y; Bai Y
Eur J Pharmacol; 2019 Aug; 857():172470. PubMed ID: 31226250
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment of mitoxantrone sensitizes breast cancer cells to rapalogs through blocking eEF-2K-mediated activation of Akt and autophagy.
Guan Y; Jiang S; Ye W; Ren X; Wang X; Zhang Y; Yin M; Wang K; Tao Y; Yang J; Cao D; Cheng Y
Cell Death Dis; 2020 Nov; 11(11):948. PubMed ID: 33144562
[TBL] [Abstract][Full Text] [Related]
6. The molecular mechanism of eukaryotic elongation factor 2 kinase activation.
Tavares CD; Ferguson SB; Giles DH; Wang Q; Wellmann RM; O'Brien JP; Warthaka M; Brodbelt JS; Ren P; Dalby KN
J Biol Chem; 2014 Aug; 289(34):23901-16. PubMed ID: 25012662
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of elongation factor-2 kinase differentially regulates the enzyme's stability under stress conditions.
Huber-Keener KJ; Evans BR; Ren X; Cheng Y; Zhang Y; Hait WN; Yang JM
Biochem Biophys Res Commun; 2012 Jul; 424(2):308-14. PubMed ID: 22749997
[TBL] [Abstract][Full Text] [Related]
8. Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion.
Ashour AA; Gurbuz N; Alpay SN; Abdel-Aziz AA; Mansour AM; Huo L; Ozpolat B
J Cell Mol Med; 2014 Nov; 18(11):2235-51. PubMed ID: 25215932
[TBL] [Abstract][Full Text] [Related]
9. Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells.
Ashour AA; Abdel-Aziz AA; Mansour AM; Alpay SN; Huo L; Ozpolat B
Apoptosis; 2014 Jan; 19(1):241-58. PubMed ID: 24193916
[TBL] [Abstract][Full Text] [Related]
10. Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor.
Piserchio A; Isiorho EA; Dalby KN; Ghose R
J Biol Chem; 2023 Jun; 299(6):104813. PubMed ID: 37172726
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic elongation factor-2 kinase regulates the cross-talk between autophagy and pyroptosis in doxorubicin-treated human melanoma cells in vitro.
Yu P; Wang HY; Tian M; Li AX; Chen XS; Wang XL; Zhang Y; Cheng Y
Acta Pharmacol Sin; 2019 Sep; 40(9):1237-1244. PubMed ID: 30914761
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of tagless recombinant human elongation factor 2 kinase (eEF-2K) expressed in Escherichia coli.
Abramczyk O; Tavares CD; Devkota AK; Ryazanov AG; Turk BE; Riggs AF; Ozpolat B; Dalby KN
Protein Expr Purif; 2011 Oct; 79(2):237-44. PubMed ID: 21605678
[TBL] [Abstract][Full Text] [Related]
13. ADP enhances the allosteric activation of eukaryotic elongation factor 2 kinase by calmodulin.
Piserchio A; Long KJ; Browning LS; Bohanon AL; Isiorho EA; Dalby KN; Ghose R
Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2300902120. PubMed ID: 37068230
[TBL] [Abstract][Full Text] [Related]
14. Modified gold-based siRNA nanotherapeutics for targeted therapy of triple-negative breast cancer.
Shahbazi R; Asik E; Kahraman N; Turk M; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2017 Aug; 12(16):1961-1973. PubMed ID: 28745127
[TBL] [Abstract][Full Text] [Related]
15. Signal Integration at Elongation Factor 2 Kinase: THE ROLES OF CALCIUM, CALMODULIN, AND SER-500 PHOSPHORYLATION.
Tavares CDJ; Giles DH; Stancu G; Chitjian CA; Ferguson SB; Wellmann RM; Kaoud TS; Ghose R; Dalby KN
J Biol Chem; 2017 Feb; 292(5):2032-2045. PubMed ID: 27956550
[TBL] [Abstract][Full Text] [Related]
16. Regulation of elongation factor-2 kinase by pH.
Dorovkov MV; Pavur KS; Petrov AN; Ryazanov AG
Biochemistry; 2002 Nov; 41(45):13444-50. PubMed ID: 12416990
[TBL] [Abstract][Full Text] [Related]
17. Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact.
Devkota AK; Tavares CD; Warthaka M; Abramczyk O; Marshall KD; Kaoud TS; Gorgulu K; Ozpolat B; Dalby KN
Biochemistry; 2012 Mar; 51(10):2100-12. PubMed ID: 22352903
[TBL] [Abstract][Full Text] [Related]
18. eEF-2 Kinase-targeted miR-449b confers radiation sensitivity to cancer cells.
Ji C; Xu Q; Guo L; Wang X; Ren Y; Zhang H; Zhu W; Ming Z; Yuan Y; Ren X; Song J; Cheng Y; Yang J; Zhang Y
Cancer Lett; 2018 Apr; 418():64-74. PubMed ID: 29331413
[TBL] [Abstract][Full Text] [Related]
19. Structural Basis for the Recognition of Eukaryotic Elongation Factor 2 Kinase by Calmodulin.
Lee K; Alphonse S; Piserchio A; Tavares CD; Giles DH; Wellmann RM; Dalby KN; Ghose R
Structure; 2016 Sep; 24(9):1441-51. PubMed ID: 27499441
[TBL] [Abstract][Full Text] [Related]
20. A critical role of eEF-2K in mediating autophagy in response to multiple cellular stresses.
Py BF; Boyce M; Yuan J
Autophagy; 2009 Apr; 5(3):393-6. PubMed ID: 19221463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
